Switzerland· 53924026
Rebalance 250, Filmtabletten
A hyperici herba product containing hyperici herbae extractum siccum quantificatum (hypericum perforatum l., herba), registered in Switzerland by Zeller Medical AG and dispensed under Swissmedic category D, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Hyperici herba is registered in 7 of 19 countries.
Countries holding a registration under ATC N06AX25 (hyperici herba), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 4 of them publish a price we can compare per daily dose
Hyperici herba · ATC N06AX25
7 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- hyperici herbae extractum siccum quantificatum (Hypericum perforatum L., herba)
- Manufacturer
- Zeller Medical AG
- Country
- Switzerland (CH)
- ATC code
- N06AX25
- ATC class
- Hyperici herba
- Swissmedic category
- D
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680539240264120 StkCHF 51.6
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
293 interactions on record for hyperici herba.
Graded by severity as the source publishes them — 141 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hyperici herba · interactions on record
293 records
- 141 severe
- 144 moderate
- 8 minor
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06AX25
Hyperici herba, as other registers publish it.
- NetherlandsA.Vogel Hyperiforce, tablettenA.Vogel B.V.
- SwitzerlandDeprivita
- SwitzerlandDeprivita
- SwitzerlandDeprivita, FilmtablettenPermamed AG
- SwitzerlandEssenssia 250 mg, comprimés pelliculésLabatec Pharma SA
- SwitzerlandEssenssia 500 mg, comprimés pelliculésLabatec Pharma SA
- FinlandHyperiforce NovaA. Vogel Oy
- SwitzerlandHyperiforce, TablettenA.Vogel AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/debba790-c43d-4f1d-a0fa-f6b1a5094b5a GET /v1/drugs/debba790-c43d-4f1d-a0fa-f6b1a5094b5a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "hyperici herbae extractum siccum quantificatum 250 mg",
"valid_from": "1997-03-15",
"limitations": null,
"galenic_form": "Filmtabl 250 mg",
"therapeutic_area": null,
"sl_inclusion_date": "1997-03-15",
"self_retention_pct": 10
}See everything about hyperici herba.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.